Evidence map›Paper›PMID 34976058›Full record

ArticleJournal of oncology2021

Relationship between High Expression of Kaiso Protein and Poor Prognosis of Lung Cancer and the Regulation Mechanism of Malignant Phenotype of Lung Cancer Cells.

Shasha Zhu, Ning Zhou, Ning Ding, Shanshan Li, Xiaoxing Liu, Guangming Ren, Qingling Li, Min Zhou

Open access · hybridAbstract read
In one paragraph

Article in Journal of oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Shasha ZhuThe Department of Respiratory, The Affiliated Xuzhou First People's Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Ning ZhouThe Department of Respiratory, The Affiliated Xuzhou First People's Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Ning DingThe Department of Respiratory, The Affiliated Xuzhou First People's Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Shanshan LiThe Department of Respiratory, The Affiliated Xuzhou First People's Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Xiaoxing LiuThe Department of Respiratory, The Affiliated Xuzhou First People's Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Guangming RenThe Department of Respiratory, The Affiliated Xuzhou First People's Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Qingling LiThe Department of Respiratory, The Affiliated Xuzhou First People's Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Min ZhouThe Department of Respiratory, The Affiliated Xuzhou First People's Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.ORCID https://orcid.org/0000-0003-2809-809X
Xuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, Kaiso was discovered to be a unique member of the POZ-zinc fingers family of transcription factors, which has been implicated in the genesis and progression of cancer. Although there is still some debate, Kaiso is believed to be implicated in the development of human cancer. It should be noted that there is minimal evidence available on the therapeutic relevance of nuclear Kaiso in lung cancer in humans. Histone or DNA modifications that control gene activity outside of the underlying sequence are examples of epigenetic alternations. Epigenetic alterations are heritable but reversible. Human illness, such as lung cancer, is often related to epigenetic dysregulation. In preclinical and clinical studies, epigenetic-targeted therapy has shown significant therapeutic promise for solid tumours and has been used in the treatment of haematological malignancies using different medicines targeting epigenetic regulators. It is important to note that the abnormal activities of Kaiso enzymes in tumour growth are summarised below and the development of inhibitors or medicines targeting epigenetic enzyme regulation is highlighted.

Identifiers

PMID34976058
PMCPMC8716232
OpenAlexW4200310682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.